129 related articles for article (PubMed ID: 2591520)
21. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Pranzatelli MR; Dollison AM; Hlibczuk V
Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the non-specific effects of catecholamine and serotonin neurotoxins by injection into the medial forebrain bundle of the rat.
Lorden JF; Oltmans GA; Dawson R; Callahan M
Pharmacol Biochem Behav; 1979 Jan; 10(1):79-86. PubMed ID: 312504
[TBL] [Abstract][Full Text] [Related]
24. 5,7-Dihydroxytryptamine-induced lesions of serotonergic neurons and desipramine-induced down-regulation of cortical beta adrenoceptors: a re-evaluation.
Manier DH; Gillespie DD; Sulser F
Biochem Pharmacol; 1987 Oct; 36(19):3308-10. PubMed ID: 2822049
[No Abstract] [Full Text] [Related]
25. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
Kamei J; Ogawa M; Kasuya Y
Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
[TBL] [Abstract][Full Text] [Related]
26. 5,7-Dihydroxitryptamine toxicity to serotonergic neurons in serum free raphe cultures.
Capela JP; Lautenschlager M; Dirnagl U; Bastos ML; Carvalho F; Meisel A
Eur J Pharmacol; 2008 Jul; 588(2-3):232-8. PubMed ID: 18519135
[TBL] [Abstract][Full Text] [Related]
27. Vulnerability to aging in the rat serotonergic system.
Nishimura A; Ueda S; Takeuchi Y; Matsushita H; Sawada T; Kawata M
Acta Neuropathol; 1998 Dec; 96(6):581-95. PubMed ID: 9845288
[TBL] [Abstract][Full Text] [Related]
28. The amine-depleting effects of 5,7-dihydroxytryptamine (5,7-DHT) in C57BL/6 mice do not increase with age.
Finnegan KT; DeLanney LE; Irwin I; Ricaurte GA; Langston JW
Brain Res; 1989 Sep; 496(1-2):251-6. PubMed ID: 2804634
[TBL] [Abstract][Full Text] [Related]
29. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord.
Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR
Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880
[TBL] [Abstract][Full Text] [Related]
30. Olfactory disturbance induced by deafferentation of serotonergic fibers in the olfactory bulb.
Moriizumi T; Tsukatani T; Sakashita H; Miwa T
Neuroscience; 1994 Aug; 61(4):733-8. PubMed ID: 7838372
[TBL] [Abstract][Full Text] [Related]
31. Effects of indolic neurotoxins on enteric serotonergic neurons.
Gershon MD; Sherman DL; Dreyfus CF
J Comp Neurol; 1980 Apr; 190(3):581-96. PubMed ID: 7391271
[TBL] [Abstract][Full Text] [Related]
32. Serotonergic lesion of median raphe nucleus alters nerve growth factor content and vulnerability of cholinergic septohippocampal neurons in rat.
Hellweg R; Thomas H; Arnswald A; von Richthofen S; Kay S; Fink H; Morgenstern R; Hörtnagl H
Brain Res; 2001 Jul; 907(1-2):100-8. PubMed ID: 11430890
[TBL] [Abstract][Full Text] [Related]
33. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
[TBL] [Abstract][Full Text] [Related]
34. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
35. Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. I. Effects of electrolytic or neurotoxic lesions of the dorsal and/or median raphé nucleus.
Cudennec A; Duverger D; Nishikawa T; McRae-Degueurce A; MacKenzie ET; Scatton B
Brain Res; 1988 Mar; 444(2):214-26. PubMed ID: 3359293
[TBL] [Abstract][Full Text] [Related]
36. 5,6-Dihydroxytryptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain.
Commins DL; Axt KJ; Vosmer G; Seiden LS
Brain Res; 1987 Feb; 403(1):7-14. PubMed ID: 2435369
[TBL] [Abstract][Full Text] [Related]
37. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
Fischette CT; Nock B; Renner K
Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
[TBL] [Abstract][Full Text] [Related]
38. Improved immunohistochemical visualization of central serotonin nerves after loading with 5,7-dihydroxytryptamine.
Howe PR; Cuello AC; Costa M; Furness JB
Neurosci Lett; 1982 Mar; 29(1):1-6. PubMed ID: 7041011
[TBL] [Abstract][Full Text] [Related]
39. Changes in activity and mRNA for rat tryptophan hydroxylase and aromatic L-amino acid decarboxylase of brain serotonergic cell bodies and terminals following neonatal 5,7-dihydroxytryptamine.
Park DH; Stone DM; Baker H; Wessel TC; Kim KS; Towle AC; Joh TH
Brain Res; 1993 Apr; 609(1-2):59-66. PubMed ID: 8508321
[TBL] [Abstract][Full Text] [Related]
40. Localization of GABAA and GABAB receptor subtypes on serotonergic neurons.
Mennini T; Gobbi M; Romandini S
Brain Res; 1986 Apr; 371(2):372-5. PubMed ID: 3008948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
